Targeting the urokinase plasminogen activation pathway reduces PDAC cancer progression.

被引：0
|
作者：
Chowdhury, Nayela N. [1 ]
Yang, Yi [2 ]
Shen, Yingnan [3 ]
Davey, Keely G. [2 ]
Han, Bumsoo [3 ]
Wolberg, Alisa [2 ]
Flick, Matthew J. [2 ]
Fishel, Melissa L. [1 ]
机构：
[1] Indiana Univ, Sch Med, Indianapolis, IN 46208 USA
[2] Univ N Carolina, Chapel Hill, NC 27515 USA
[3] Purdue Univ, W Lafayette, IN 47907 USA
来源：
CANCER RESEARCH | 2021年 / 81卷 / 13期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2002
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Targeting the urokinase plasminogen activator pathway inhibits pancreatic cancer progression
    Hosen, S. M. Z.
    Haar, J.
    Xu, Z.
    Perera, C.
    Mekapogu, A. R.
    Pang, T. C. Y.
    Pothula, S.
    Goldstein, D.
    Pirola, R.
    Wilson, J.
    Buckley, B. J.
    Ranson, M.
    Apte, M.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2021, 36 : 25 - 26
  • [2] Targeting the Urokinase Plasminogen Activator Pathway in Combination With Chemotherapy Inhibits Pancreatic Cancer Progression
    Hosen, S. M. Z.
    Xu, Z.
    Perera, C.
    Mekapogu, A. R.
    Pang, T. C. Y.
    Goldstein, D.
    Pirola, R. C.
    Wilson, J. S.
    Buckley, B. J.
    Ranson, M.
    Apte, M. V.
    PANCREAS, 2021, 50 (07) : 1065 - 1065
  • [3] ACTIVATION PATHWAY OF GLU-PLASMINOGEN TO LYS-PLASMIN BY UROKINASE
    TAKADA, A
    TAKADA, Y
    THROMBOSIS RESEARCH, 1982, 27 (06) : 671 - 677
  • [4] Association of the circulating levels of the urokinase system of plasminogen activation with the presence of prostate cancer and invasion, progression, and metastasis
    Shariat, Shahrokh F.
    Roehrborn, Claus G.
    McConnell, John D.
    Park, Sangtae
    Alam, Nina
    Wheeler, Thomas M.
    Slawin, Kevin M.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (04) : 349 - 355
  • [5] Modulators of the urokinase-type plasminogen activation system for cancer
    Hildenbrand, Ralf
    Allgayer, Heike
    Marx, Alexander
    Stroebel, Philipp
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2010, 19 (05) : 641 - 652
  • [6] Modulators of the urokinase-type plasminogen activation system for cancer
    Rosenberg, S
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2000, 10 (12) : 1843 - 1852
  • [7] Targeting the Urokinase Plasminogen Activator Receptor Inhibits Ovarian Cancer Metastasis
    Kenny, Hilary A.
    Leonhardt, Payton
    Ladanyi, Andras
    Yamada, S. Diane
    Montag, Anthony
    Im, Hae Kyung
    Jagadeeswaran, Sujatha
    Shaw, David E.
    Mazar, Andrew P.
    Lengyel, Ernst
    CLINICAL CANCER RESEARCH, 2011, 17 (03) : 459 - 471
  • [8] Association of blood levels of components of the urokinase system of plasminogen activation with prostate cancer presence, invasion, progression, and metastasis
    Shariat, Shahrokh F.
    Roehrbom, Claus G.
    McConnell, John D.
    Park, Sangtae
    Wheeler, Thomas M.
    Slawin, Kevin M.
    JOURNAL OF UROLOGY, 2007, 177 (04): : 473 - 473
  • [9] Plasminogen interaction with tissue factor pathway inhibitor - The role of urokinase activation.
    Panetta, CJ
    Stalboerger, P
    Simari, RD
    Caplice, NM
    CIRCULATION, 2001, 104 (17) : 204 - 204
  • [10] Amiloride Reduces Urokinase/Plasminogen-Driven Intratubular Complement Activation in Glomerular Proteinuria
    Isaksson, Gustaf L.
    Hinrichs, Gitte R.
    Andersen, Henrik
    Bach, Marie L.
    Weyer, Kathrin
    Zachar, Rikke
    Henriksen, Jan Erik
    Madsen, Kirsten
    Lund, Ida K.
    Mollet, Geraldine
    Bistrup, Claus
    Birn, Henrik
    Jensen, Boye L.
    Palarasah, Yaseelan
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2024, 35 (04): : 410 - 425
12345